Title: COVID-19 - Provider Relief Find and American Rescue Plan Rural Distribution
Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the federal grant activity of The New York Eye and Ear Infirmary and Affiliates (the Organization) for the year ended December 31, 2023 and is presented on the accrual basis of accounting. The information on the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). In accordance with applicable requirements, certain programs may be presented in a fiscal period based on the program-specific guidance (see Notes 3 and 4). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the presentation of, the consolidated financial statements of the Organization.
Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services (HHS) Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX for awards subject to the Uniform Guidance. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: N
Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election; however, NYEE did not make this election and uses a negotiated indirect cost rate.
In accordance with HHS requirements specific to Federal Assistance Listing No. 93.498, COVID-19 – Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution, the amount presented on the accompanying Schedule for the year ended December 31, 2023 for Federal Assistance Listing No. 93.498 relates to Provider Relief Fund (PRF) payments received from January 1, 2022 through December 31, 2022 used for PRF-eligible activity from the period January 1, 2020 through June 30, 2023.
This payment receipt period and activity period and the resulting amount presented on the accompanying Schedule for the year ended December 31, 2023 reconcile to the PRF information previously reported to the Health Resources and Services Administration (HRSA) for PRF Reporting Period 5 (See Notes to schedule of Expenditures of Federal Awards for table).
The lost revenues incurred by the Organization during the periods of availability through PRF Reporting Period 5 (January 1, 2020 to June 30, 2023) are in excess of the cumulative distributions received in PRF Reporting Periods 1, 2, 3 and 4 (which addressed payments received during the period April 10, 2020 through December 31, 2021, and previously reported on the applicable schedule of expenditures of federal awards for the years ended December 31, 2021 and 2022) and distributions received from January 1, 2022 through June 30, 2022. Therefore, the amount presented in the table above and on the accompanying Schedule is limited to the amount of distributions received in PRF Reporting Period 5.
Title: COVID-19 - Disaster Grants - Public Assistance (Presidentially Declared Disasters)
Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the federal grant activity of The New York Eye and Ear Infirmary and Affiliates (the Organization) for the year ended December 31, 2023 and is presented on the accrual basis of accounting. The information on the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). In accordance with applicable requirements, certain programs may be presented in a fiscal period based on the program-specific guidance (see Notes 3 and 4). Therefore, some amounts presented in the Schedule may differ from amounts presented in, or used in the presentation of, the consolidated financial statements of the Organization.
Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services (HHS) Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX for awards subject to the Uniform Guidance. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: N
Rate Explanation: The Uniform Guidance provides for a 10% de minimis indirect cost rate election; however, NYEE did not make this election and uses a negotiated indirect cost rate.
The Organization incurred certain expenditures related to the COVID-19 pandemic which are eligible for reimbursement from the U.S Department of Homeland Security - Federal Emergency Management Agency (FEMA) Disaster Grants – Public Assistance (Presidentially Declared Disasters) (Federal Assistance Listing No. 97.036). In 2023, the Organization recognized approximately $0.7 million of obligated reimbursement payments from FEMA. Such costs were incurred during the years ended December 31, 2020 to 2022, and approved by FEMA in 2023. These amounts have been included in the accompanying Schedule for the year ended December 31, 2023, in accordance with the guidance specific to Federal Assistance Listing No. 97.036.
The Organization will continue to finalize the project worksheets previously submitted to FEMA and intends to submit additional applications for funding for costs incurred; however, the ultimate amount that the Organization may be reimbursed is uncertain.